NPR News

Pages

Monkey See
9:49 am
Fri May 11, 2012

NBC Renews And Reduces Its Thursday-Night Comedies, And That's A Good Thing

One more ride: Tina Fey's Liz Lemon gets 13 more chances to pick up a little elevator advice from Alec Baldwin's Jack Donaghy.
Ali Goldstein NBC

Originally published on Fri May 11, 2012 2:31 pm

Everybody settle down.

Read more
Religion
9:25 am
Fri May 11, 2012

What Will Black Pastors Preach This Sunday?

Originally published on Fri May 11, 2012 2:04 pm

Transcript

MICHEL MARTIN, HOST:

I'm Michel Martin, and this is TELL ME MORE from NPR News.

Coming up, this is the month when we acknowledge the contributions of Asian-Americans and Pacific Islanders to the history and ongoing life of this country. We decided to observe it by speaking with people who have changed the game in their respective fields. Today, we are talking with Hikaru Nakamura. At the ripe old age of 24, he has already won the U.S. Championships twice and he's working on his third, as we speak. We'll have that conversation in just a few minutes.

Read more
The Two-Way
9:03 am
Fri May 11, 2012

Obama's Fundraiser At George Clooney's Home Nets Record $15 Million

A presidential SUV is seen outside of the house of actor George Clooney on Thursday in Los Angeles.
Mandel Ngan AFP/Getty Images

$15 million.

That's how much President Obama campaign will receive from a fund-raising event last night at George Clooney's home. The New York Times reports the A-list, Hollywood crowd paid $40,000 a person, helping to set "a record for a presidential election fund-raiser."

The Times adds:

Read more
Planet Money
8:59 am
Fri May 11, 2012

JP Morgan's $2 Billion Loss, Explained

Chris McGrath Getty Images

Originally published on Fri May 11, 2012 10:17 am

What just happened?

JPMorgan Chase, the biggest bank in America, announced that it lost $2 billion on a massive trade placed out of its London office.

What was the trade?

Read more
Shots - Health Blog
8:13 am
Fri May 11, 2012

FDA Gets Advice To Approve First Pill To Cut HIV Infections

Gilead Sciences' Truvada is a step closer to being approved as a way to prevent HIV infection.
Paul Sakuma AP

Originally published on Fri May 11, 2012 9:31 am

In what could mark a watershed in the fight against HIV/AIDS, a panel of experts recommended that the Food and Drug Administration give a green light to a pill that can cut the risk of infections.

The daily pill, Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's already approved as a treatment for HIV, but its use could soon expand to include protection of uninfected people.

Read more

Pages